KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Halozyme Therapeutics (HALO) Prepaid Assets (2016 - 2025)

Halozyme Therapeutics (HALO) has disclosed Prepaid Assets for 16 consecutive years, with $64.6 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets fell 45.93% to $64.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $64.6 million through Dec 2025, down 45.93% year-over-year, with the annual reading at $64.6 million for FY2025, 45.93% down from the prior year.
  • Prepaid Assets for Q4 2025 was $64.6 million at Halozyme Therapeutics, down from $150.7 million in the prior quarter.
  • The five-year high for Prepaid Assets was $150.7 million in Q3 2025, with the low at $32.7 million in Q2 2021.
  • Average Prepaid Assets over 5 years is $73.3 million, with a median of $63.8 million recorded in 2024.
  • The sharpest move saw Prepaid Assets skyrocketed 149.94% in 2024, then tumbled 45.93% in 2025.
  • Over 5 years, Prepaid Assets stood at $40.5 million in 2021, then surged by 76.19% to $71.3 million in 2022, then plummeted by 31.84% to $48.6 million in 2023, then soared by 145.92% to $119.5 million in 2024, then crashed by 45.93% to $64.6 million in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $64.6 million, $150.7 million, and $133.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.